In this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today’s IO environment.

What is the current nature and types of partnerships being done in IO?
Is dealmaking and partnerships evolving due to the need for IO combinations? How so?
What is the balance between in house R&D and external innovation in IO?
What is the decision making regarding exclusive licensing and “no strings attached” partnerships?

Save the date for IO Combinations 360° happening June 20-21, 2019 at the Wyndham Historic District Hotel, Philadelphia, PA and for IO360° happening February 26-28, 2020 at the Crowne Plaza Times Square in New York City.

IO Partnering Strategies In an Increasingly Complex Environment

Share

Embed